Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
BIDU-SW
09888
5
JD HEALTH
06618
| (Q1)Jun 30, 2025 | (FY)Mar 31, 2025 | (Q1)Jun 30, 2024 | (FY)Mar 31, 2024 | (Q4)Mar 31, 2024 | (Q3)Dec 31, 2023 | (Q2)Sep 30, 2023 | (Q1)Jun 30, 2023 | (FY)Mar 31, 2023 | (Q4)Mar 31, 2023 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Total revenue | -9.97%4.22T | -4.85%18.62T | -1.05%4.69T | -9.29%19.57T | -8.05%4.86T | -7.52%5.14T | -8.58%4.83T | -13.00%4.74T | 24.95%21.57T | 8.05%5.29T |
| Cost of revenue | -7.08%3.85T | -2.48%16.78T | 0.79%4.14T | -9.49%17.21T | -7.79%4.28T | -8.63%4.52T | -9.63%4.3T | -11.94%4.11T | 25.79%19.01T | 10.28%4.64T |
| Gross profit | -32.04%368.45B | -22.18%1.84T | -13.17%542.12B | -7.82%2.36T | -9.90%580.07B | 1.43%626.33B | 0.95%528.97B | -19.41%624.34B | 19.03%2.56T | -5.72%643.77B |
| Operating expense | -32.95%290.47B | -13.41%1.47T | 10.38%433.19B | 5.27%1.69T | 7.40%468.69B | 0.85%411.76B | 8.11%419.37B | 4.67%392.46B | 12.25%1.61T | 12.42%436.38B |
| Selling and administrative expenses | -32.95%290.47B | -13.41%1.47T | 10.38%433.19B | 5.27%1.69T | 7.40%468.69B | 0.85%411.76B | 8.11%419.37B | 4.67%392.46B | 12.25%1.61T | 12.42%436.38B |
| -General and administrative expense | -32.95%290.47B | -13.41%1.47T | 10.38%433.19B | 5.27%1.69T | 7.40%468.69B | 0.85%411.76B | 8.11%419.37B | 4.67%392.46B | 12.25%1.61T | 12.42%436.38B |
| Operating profit | -28.41%77.98B | -44.40%371.1B | -53.02%108.93B | -29.92%667.43B | -46.30%111.38B | 2.57%214.57B | -19.45%109.6B | -42.00%231.88B | 32.52%952.44B | -29.62%207.4B |
| Net non-operating interest income (expenses) | -37.81%19.39B | 50.55%171.98B | -14.47%31.18B | 29.42%114.23B | 101.43%70.69B | 32.81%8.57B | -133.94%-1.49B | -13.90%36.46B | -36.89%88.27B | 2.53%35.09B |
| Non-operating interest income | -22.56%60.15B | 12.19%342.6B | -3.31%77.67B | 49.96%305.37B | 62.93%120.52B | 45.28%58.06B | 57.71%46.47B | 33.34%80.32B | 9.17%203.64B | 60.92%73.97B |
| Non-operating interest expense | -12.33%40.76B | -10.74%170.62B | 5.97%46.49B | 65.67%191.14B | 28.18%49.83B | 47.68%49.49B | 91.13%47.96B | 145.07%43.87B | 147.16%115.38B | 231.24%38.87B |
| Net investment income | ||||||||||
| Gain(Loss) on financial instruments designated as cash flow hedges | ||||||||||
| Gain(Loss) on derecognition of available-for-sale financial assets | 137.60%19.56B | 31.17%305.63B | -81.49%8.23B | 18.27%233.01B | 279.37%164.78B | 102.06%16.9B | -26.56%6.86B | -67.27%44.47B | 161.79%197.01B | -0.23%43.43B |
| Income from associates and other participating interests | 11.00%138.72B | -24.06%337.48B | 2.52%124.97B | -11.15%444.39B | -7.09%99.22B | -1.31%117.14B | -12.52%106.12B | -20.53%121.9B | 27.01%500.18B | 41.22%106.79B |
| Special income (charges) | -103.03%-4.46B | 1,606.52%130.7B | 679.74%147.18B | 124.00%7.66B | 202.05%30.68B | -4,416.83%-42.68B | 183.28%792M | 40,934.78%18.88B | 44.80%-31.91B | 47.69%-30.06B |
| Less:Impairment of capital assets | 121.83%750M | -86.89%3.88B | -547.98%-3.44B | -6.58%29.56B | -158.92%-15.46B | 3,399.43%43.25B | -64.28%992M | -44.86%767M | -50.96%31.64B | -53.04%26.23B |
| Less:Other special charges | 102.58%3.71B | -261.62%-134.58B | -631.80%-143.75B | -13,781.99%-37.22B | -497.78%-15.22B | -95.53%-569M | 2.30%-1.78B | -1,266.95%-19.64B | 104.05%272M | 140.18%3.83B |
| Other non-operating income (expenses) | -97.78%1.74B | 173.51%76.54B | 982.78%78.37B | -310.67%-104.12B | -353.89%-119.37B | 521.75%16.52B | 352.22%7.6B | -212.71%-8.88B | -208.86%-25.35B | -552.72%-26.3B |
| Income before tax | -49.30%252.92B | 2.26%1.39T | 12.18%498.87B | -18.92%1.36T | 6.25%357.38B | -2.02%331.03B | -14.09%229.49B | -39.85%444.7B | 29.97%1.68T | -12.99%336.36B |
| Income tax | -66.64%32.29B | -6.09%317.18B | -0.48%96.79B | -17.45%337.74B | 26.77%114.14B | -7.09%69.37B | -10.23%56.97B | -46.26%97.26B | 41.74%409.13B | -2.44%90.04B |
| Net income | -45.13%220.63B | 5.01%1.08T | 15.72%402.08B | -19.40%1.02T | -1.25%243.24B | -0.58%261.66B | -15.29%172.52B | -37.77%347.44B | 26.59%1.27T | -16.29%246.32B |
| Net income continuous operations | -45.13%220.63B | 5.01%1.08T | 15.72%402.08B | -19.40%1.02T | -1.25%243.24B | -0.58%261.66B | -15.29%172.52B | -37.77%347.44B | 26.59%1.27T | -16.29%246.32B |
| Noncontrolling interests | -63.31%17.51B | 106.39%125.54B | 60.55%47.72B | -33.02%60.82B | -213.08%-24.18B | 13.43%31.12B | 37.22%24.16B | 21.92%29.72B | 35.67%90.81B | 1,320.86%21.38B |
| Net income attributable to the company | -42.68%203.12B | -1.38%950.71B | 11.53%354.36B | -18.35%964.03B | 18.89%267.42B | -2.21%230.54B | -20.26%148.36B | -40.50%317.72B | 25.94%1.18T | -23.17%224.94B |
| Preferred stock dividends | ||||||||||
| Other under preferred stock dividend | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Net income attributable to common stockholders | -42.68%203.12B | -1.38%950.71B | 11.53%354.36B | -18.35%964.03B | 18.89%267.42B | -2.21%230.54B | -20.26%148.36B | -40.50%317.72B | 25.94%1.18T | -23.17%224.94B |
| Gross dividend payment | ||||||||||
| Basic earnings per share | -40.65%51.59 | 2.99%236.97 | 16.66%86.93 | -14.70%230.1 | 24.13%64.67 | 2.59%55.39 | -16.92%35.2567 | -38.28%74.5167 | 27.43%269.76 | -21.18%52.1 |
| Diluted earnings per share | -40.65%51.34 | 6.04%235.8 | 16.61%86.51 | -17.20%222.37 | 11.27%57.67 | 2.57%55.15 | -16.96%35.0967 | -38.30%74.1867 | 28.76%268.56 | -18.36%51.83 |
| Dividend per share | 0 | 42.86%100 | 0 | 16.67%70 | 1.94%35 | 0 | 36.36%35 | 0 | 20.00%60 | 30.38%34.3333 |
| Currency Unit | JPY | JPY | JPY | JPY | JPY | JPY | JPY | JPY | JPY | JPY |
| Accounting Standards | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP |